CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients
CONTAIN COVID-19: Convalescent Plasma to Limit Coronavirus Associated Complications: a Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV2 Plasma to Placebo in COVID-19 Hospitalized Patients
Sponsor: Albert Einstein College of Medicine
A PHASE2 clinical study on COVID-19 and Coronavirus, this trial is completed. The trial is conducted by Albert Einstein College of Medicine and has accumulated 15 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Oct 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE2
▶ Show 10 earlier versions
-
May 2022 — Oct 2022 [monthly]
Active Not Recruiting PHASE2
-
Oct 2021 — May 2022 [monthly]
Active Not Recruiting PHASE2
-
Jun 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE2
-
Apr 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Jul 2020 — Sep 2020 [monthly]
Recruiting PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE2
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE2
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Einstein College of Medicine
- NYU Langone Health
- National Center for Advancing Translational Sciences (NCATS)
- The University of Texas Health Science Center at Tyler
- The University of Texas Health Science Center, Houston
- University of Miami
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .